GOCOVRI (Adamas Pharma, LLC)


Welcome to the PulseAid listing for the GOCOVRI drug offered from Adamas Pharma, LLC. This Influenza A M2 Protein Inhibitor [EPC],M2 Protein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Adamas Pharma, LLC
NON-PROPRIETARY NAME: AMANTADINE
SUBSTANCE NAME: AMANTADINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Influenza A M2 Protein Inhibitor [EPC],M2 Protein Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: CAPSULE, COATED PELLETS
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2017-08-24
END MARKETING DATE: 0000-00-00


GOCOVRI HUMAN PRESCRIPTION DRUG Details:

Item DescriptionGOCOVRI from Adamas Pharma, LLC
LABELER NAME: Adamas Pharma, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 68.5(mg/1)
START MARKETING DATE: 2017-08-24
END MARKETING DATE: 0000-00-00
PRODUCT ID: 70482-085_fc8ae634-62f8-4ef2-b01b-4f6ff25b59b5
PRODUCT NDC: 70482-085
APPLICATION NUMBER: NDA208944

Other AMANTADINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Adamas Pharma, LLCGOCOVRI